Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)

v3.19.1
CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Total
Balances at beginning at Dec. 31, 2017 $ 288 $ 24,712 $ (1,176) $ 23,824
Balances at beginning (in shares) at Dec. 31, 2017 2,875,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Sale of Units, net of underwriting discounts and offering expenses $ 1,150 112,266,904 112,268,054
Sale of Units, net of underwriting discounts and offering expenses (in shares) 11,500,000      
Sale of Private Placement Units $ 45 4,449,955 4,450,000
Sale of Private Placement Units (in shares) 445,000      
Proceeds from the sale of unit purchase option 100 100
Common stock subject to possible redemption $ (1,107) (111,763,319) (111,764,426)
Common stock subject to possible redemption (in shares) (11,061,794)      
Net income 22,449 22,449
Balances at ending at Mar. 31, 2018 $ 376 4,978,352 21,273 5,000,001
Balances at ending (in shares) at Mar. 31, 2018 3,758,206      
Balances at beginning at Dec. 31, 2018 $ 379 3,979,089 1,020,535 5,000,003
Balances at beginning (in shares) at Dec. 31, 2018 3,789,558      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Sale of Private Placement Units      
Proceeds from the sale of unit purchase option      
Change in value of common stock subject to redemption $ 1 (380,236) (380,235)
Change in value of common stock subject to redemption (in shares) 10,775      
Net income 380,241 380,241
Balances at ending at Mar. 31, 2019 $ 380 $ 3,598,853 $ 1,400,776 $ 5,000,009
Balances at ending (in shares) at Mar. 31, 2019 3,800,333